FINWIRES · TerminalLIVE
FINWIRES

中国制造业增速放缓,贸易形势喜忧参半;世纪华通股价下跌9%

By

-- 周四,受中国制造业增速放缓以及劳动节假期临近的影响,中国股市涨跌互现。 衡量中国股市的主要指标——上证综指上涨0.1%,收于4112.16点。深证成指下跌0.1%,收于15107.55点。 4月份中国制造业采购经理人指数(PMI)环比下降0.1个百分点,至50.3%。 生产和新订单分项指数分别保持在51.5%和50.6%的临界点以上。原材料、就业和供应商交货时间等其他分项指数则分别低于临界点,分别为49.3%、48.8%和49.5%。 与此同时,非制造业商业活动指数为49.4%,环比下降0.7个百分点。综合PMI产出指数为50.1%,下降0.4个百分点。 公司新闻方面,浙江世纪华通集团(SHE:002602)公布第一季度归属于母公司股东的净利润为20.3亿元人民币,较上年同期的13.5亿元人民币增长35%。这家游戏开发商的股价周四下跌了9%。

Related Articles

Equities

Berenberg Adjusts Estimates for Galp Energia After 'Solid' Q1 Results; Hold Rating Maintained

Berenberg updated its earnings forecasts for Galp Energia (GALP.LS) after the Portuguese energy company reported its first-quarter results."Galp reported a solid set of results for Q126 on 27 April from an operational point of view, and beat consensus EBITDA expectations, although this was offset by some cash flow adjustments in the period. Delivery of the important Bacalhau project (Brazil) appears to be ahead of expectations, and, after a strong Q1 in the refining business, Galp is moving towards confirming the terms of its downstream merger with Moeve. In the earnings call, the company indicated that its 2026 guidance is now likely out of date given the macro backdrop, and that it may update its FY26 outlook in the Q2 results. We leave our Hold rating and EUR20 price target unchanged," the research firm said Wednesday.Against this backdrop, the research firm increased its 2026 EBITDA assumption by 3%, while cutting its cash flow from operations and free cash flow estimates by 4% and 3%, respectively, to account for a recent 320 million-euro renewable acquisition and other liquidity adjustments.Meanwhile, analysts maintained their share repurchase projection for 2026 at 250 million euros, while boosting their 2027 forecast to 455 million euros, which is 10% above consensus. Berenberg's EPS estimates for 2026 through 2028 were also revised upwards.

$GALP.LS
Asia

Henlius Biotech Doses First Patient in Lung Cancer Drug Trial in China

Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a phase 1 clinical study of HLX3901 in mainland China, according to a Thursday Hong Kong bourse filing.The drug is being tested for the treatment of patients with advanced small-cell lung cancer or neuroendocrine carcinoma.

$HKG:2696
Equities

BP Confirms Preliminary Offshore Exploration Agreement With Venezuela

BP (BP.L) entered into a memorandum of understanding with the Bolivarian Republic of Venezuela to establish "potential areas for co‑operation in material offshore gas and future exploration," according to a statement sent toon Thursday.Venezuela's Acting President Delcy Rodríguez announced in a Wednesday signing event its offshore natural gas exploration deal with the British oil major, which covers the Deltana Platform, an oil and natural gas reservoir in the nation's eastern waters, according to a same-day report from Bloomberg News.BP Executive Vice President William Lin also said the company plans to launch a permanent regional office in Caracas, Venezuela.

$BP.L